These findings identify CELSR2 as a previously unknown regulator of epithelial-mesenchymal plasticity and reveal that heterogeneous CELSR2 expression shapes spatially and functionally distinct tumor cell populations, thereby contributing to intratumoral heterogeneity in TNBC.
Results implicate TNIK in the mechanisms linking epithelial-mesenchymal plasticity with proliferation and evasion of senescence and provide insights into future strategies for the clinical deployment of TNIK inhibitors in LUSC and other TNIK-dependent malignancies.
Mohaddase Hamidi, Kenneth O. Omolo, Korrey W. Hart et al.· bioRxiv· 0 citations
Metastatic progression in triple-negative breast cancer (TNBC) is strongly influenced by epithelial-mesenchymal plasticity (EMP), which enables transitions between epithelial, hybrid epithelial/mesenchymal (E/M), and mesenchymal cell states. While mesenchymal cells are highly invasive and resistant to therapy, hybrid E...
Wen-Chao Liu, Hoi-Wan Lee, M. Bungert et al.· bioRxiv· 0 citations
A high-resolution single-cell transcriptomic atlas of the ESCC tumor microenvironment is constructed via single-cell RNA sequencing of 15 tissue specimens derived from 8 ESCC patients, revealing Fibro_myo_C1 as a prominent fibroblast subset associated with ESCC progression that orchestrates stromal crosstalk to drive m...
Xiao-Wei Chen, Yuan-Yuan Lei, Da-Zhi Pang et al.· Cancer Letters· 0 citations
Elevated MXRA5 expression exhibited a positive correlation with advanced lymph node metastasis and impaired clinical prognosis, and its potential as a valuable prognostic biomarker and therapeutic target for managing metastatic disease is revealed.
Jian Wang, Jie Tang, Yaoxin Wang· Korean Journal of Physiology...· 0 citations
It is suggested that the c-Myc-ALOX5 pathway promotes ccRCC progression by enhancing tumor cell aggressiveness and M2 macrophage polarization, offering a potential therapeutic target for immune microenvironment modulation in renal cancer.
Chang-Jie Ren, Yi-Jun Tian, Xin-Ran Zhang et al.· American Journal of Cancer R...· 0 citations
Metastasis and associated therapy resistance remain the principal drivers of cancer related death, and there is a pressing need for a deeper mechanistic understanding and anti-metastatic therapies. For patients that suffer from hepatocellular carcinomas (HCCs), which are the most common primary liver cancers, frequent...
T. A. Rants'o, Kathryn Woods, Paige Jensen et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.